Lactobacillus Bacteremia during a Rapid Increase in Probiotic Use of Lactobacillus rhamnosus GG in Finland
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Lactobacilli supposedly have low pathogenicity; they are seldom detected in blood culture. Lactobacillus rhamnosus GG, which originates indigenously in the human intestine, became available for use as a probiotic in 1990 in Finland. We evaluated the possible effects of the increased probiotic use of L. rhamnosus GG on the occurrence of bacteremia due to lactobacilli. Lactobacilli were isolated in 0.02% of all blood cultures and 0.2% of all blood cultures with positive results in Helsinki University Central Hospital and in Finland as a whole, and no trends were seen that suggested an increase in Lactobacillus bacteremia. The average incidence was 0.3 cases/100,000 inhabitants/year in 1995-2000 in Finland. Identification to the species level was done for 66 cases of Lactobacillus bacteremia, and 48 isolates were confirmed to be Lactobacillus strains. Twenty-six of these strains were L. rhamnosus, and 11 isolates were identical to L. rhamnosus GG. The results indicate that increased probiotic use of L. rhamnosus GG has not led to an increase in Lactobacillus bacteremia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The prevalence of LB is generally low, comprising 0.1–0.2% of all isolates identified in blood cultures from hospitalized patients and 0.5% of blood isolates from immunocompromised patients [2,10,18,19,20].”
From Lactobacillus Bacteremia and Probiotics: A Review (2023) · cites this paper as [20]
In the citing paper
“However, even when the use of this probiotic increased, no increase in the incidence of LB was found, with an average incidence of 0.29 cases/100,000 inhabitants/year between 1995 and 2000.”
From Lactobacillus Bacteremia and Probiotics: A Review (2023) · cites this paper as [20]
Citations
Cites
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial
Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., & Isolauri, E. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04259-8 · Cited by 2,432
Probiotics in the management of atopic eczema
Isolauri, E., Arvola, T., SÜtas, Y., Moilanen, E., & Salminen, S. (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00943.x · Cited by 974
Probiotics: A novel approach in the management of food allergy
Majamaa, H., & Isolauri, E. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70093-9 · Cited by 918
Demonstration of safety of probiotics—A review
Salminen, S. (1998) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(98)00128-7 · Cited by 884
Fuller, R. (1991) · Gut · doi:10.1136/gut.32.4.439 · Cited by 862
Probiotic Spectra of Lactic Acid Bacteria (LAB)
Naidu, A. S., Bidlack, W. R., & Clemens, R. A. (1999) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408699991279187 · Cited by 698
Isolauri, E., Juntunen, M., Rautanen, T., Sillanaukee, P., & Koivula, T. (1991) · PubMed · Cited by 684
Survival ofLactobacillus species (strain GG) in human gastrointestinal tract
Goldin, B. R., Gorbach, S. L., Saxelin, M., Barakat, S., Gualtieri, L., & Salminen, S. (1992) · Digestive Diseases and Sciences · doi:10.1007/bf01308354 · Cited by 554
Self-citationLactic Acid Bacteria in the Treatment of Acute Rotavirus Gastroenteritis
Majamaa, H., Isolauri, E., Saxelin, M., & Vesikari, T. (1995) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.1995.tb11561.x · Cited by 552
Self-citationAlander, M., Satokari, R., Korpela, R., Saxelin, M., Vilpponen-Salmela, T., Mattila-Sandholm, T., & von Wright, A. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.1.351-354.1999 · Cited by 530
Self-citationLactic acid bacteria and human clinical infection
Aguirre, M., & Collins, M. D. (1993) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1993.tb02753.x · Cited by 425
Liver Abscess Due to a Lactobacillus rhamnosus Strain Indistinguishable from L. rhamnosus Strain GG
Rautio, M., Jousimies‐Somer, H., Kauma, H., Pietarinen, I., Saxelin, M., Tynkkynen, S., & Koskela, M. (1999) · Clinical Infectious Diseases · doi:10.1086/514766 · Cited by 327
Self-citationLactobacillus bacteremia and endocarditis: Review of 45 cases
Husni, R. N., Gordon, S. M., Washington, J. A., & Longworth, D. L. (1997) · Clinical Infectious Diseases · doi:10.1086/516109 · Cited by 270
Lactobacillus endocarditis caused by a probiotic organism
Mackay, A. D., Taylor, M. B., Kibbler, C. C., & Hamilton-Miller, J. M. T. (1999) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1999.tb00144.x · Cited by 264
Tynkkynen, S., Satokari, R., Saarela, M., Mattila-Sandholm, T., & Saxelin, M. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.9.3908-3914.1999 · Cited by 229
Self-citationKullen, M. J., Sanozky-Dawes, R. B., Crowell, D. C., & Klaenhammer, T. R. (2000) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2000.01146.x · Cited by 199
(1994) · Bulletin de l Institut Pasteur · Cited by 194
Lactobacilli and Bacteremia in Southern Finland, 1989-1992
Saxelin, M., Chuang, N.-H., Chassy, B., Rautelin, H., Makela, P. H., Salminen, S., & Gorbach, S. L. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.3.564 · Cited by 186
Self-citationLactobacillus Bacteremia: Description of the Clinical Course in Adult Patients Without Endocarditis
Antony, S. J., Stratton, C. W., & Dummer, J. S. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.4.773 · Cited by 116
Lactobacillemia in three patients with AIDS
Horwitch, C. A., Furseth, H. A., Larson, A. M., Jones, T. L., Olliffe, J. F., & Spach, D. H. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1460 · Cited by 78
Are live saccharom yces yeasts harmful to patients?
Piarroux, R., Millon, L., Bardonnet, K., Vagner, O., & Koenig, H. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02001-2 · Cited by 77
Lactobacillus Species as Opportunistic Pathogens in Immunocompromised Patients
Schlegel, L., Lemerle, S., & Geslin, P. (1998) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050216 · Cited by 69
Lactobacillus casei subsp. rhamnosus Sepsis in a Patient With Ulcerative Colitis
Farina, C., Arosio, M. E. G., Mangia, M., & Moioli, F. (2001) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200109000-00019 · Cited by 65
Parola, P., Maurin, M., Alimi, Y., Juhan, C., & Brouqui, P. (1998) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01691119 · Cited by 14
Research works printed but not linked: 5
- Gasser F, 1994, Bull Inst Pasteur, 92, 45
- Parola P, 1998, Eur J Clin Microbiol Infect Dis, 17, 203
- Isolauri E, 1991, Pediatrics, 88, 90
- Majamaa H, 1995, J Pediatr Gastroenterol Nutr, 20, 333, 10.1097/00005176-199504000-00012 · doi:10.1097/00005176-199504000-00012 · Paper page
- Seeber GUH, 1998, London: John Wiley & Sons, 3404
Cited by
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections
Surawicz, C. M., Brandt, L. J., Binion, D. G., Ananthakrishnan, A. N., Curry, S. R., Gilligan, P. H., McFarland, L. V., Mellow, M., & Zuckerbraun, B. S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.4 · Cited by 1,645
Probiotics, Prebiotics, and Synbiotics
de Vrese, M., & Schrezenmeir, J. (2008) · Advances in Biochemical Engineering/Biotechnology · doi:10.1007/10_2008_097 · Cited by 1,028
Doron, S., & Snydman, D. R. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ085 · Cited by 942
Rachmilewitz, D., Katakura, K., Karmeli, F., Hayashi, T., Reinus, C., Rudensky, B., Akira, S., Takeda, K., Lee, J., Takabayashi, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.019 · Cited by 859
Safety assessment of probiotics for human use
Sanders, M. E., Akkermans, L. M. A., Haller, D., Hammerman, C., Heimbach, J. T., Hörmannsperger, G., & Huys, G. (2010) · Gut Microbes · doi:10.4161/gmic.1.3.12127 · Cited by 816
Metadata
- Authors
- Salminen, M. K., Tynkkynen, S., Rautelin, H., Saxelin, M., Vaara, M., Ruutu, P., Sarna, S., Valtonen, V., & Järvinen, A.
- Affiliations
- Helsinki University Hospital (FI)
- Valio (Finland) (FI)
- University of Helsinki (FI)
- Corresponding author
- Salminen, Minna K.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-11-15
- Volume
- 35
- Issue
- 10
- Pages
- 1155-1160
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2104684779
- Cited by
- 419
- References
- 24
- Citations by year
- 2026: 13 · 2025: 10 · 2024: 4 · 2023: 16 · 2022: 18 · 2021: 14 · 2020: 13 · 2019: 18 · 2018: 19 · 2017: 20 · 2016: 18 · 2015: 18 · 2014: 21 · 2013: 20 · 2012: 23
- FWCI
- 27.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- Kela
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- Lactobacillus rhamnosus GG, probiotics, blood culture, Lactobacillus rhamnosus, probiotic safety, Finland
- MeSH terms
- Finland, Humans, Lactobacillus, Bacteremia, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.